Treatment Action Group (TAG) is proud to announce Dr. Richard Lynn — scientist, activist, philanthropist, and founding member of TAG — as the third and final honoree for the 2025 Research in Action Awards (RIAA), to be held on October 20 at the Angel Orensanz Foundation in New York City.
Treatment Action Group (TAG) is proud to announce that Dr. Jeanne Marrazzo, MD, MPH, FACP, FIDSA, will be honored at the 2025 Research in Action Awards (RIAA) for her groundbreaking contributions to infectious disease research
Treatment Action Group (TAG) is proud to announce that Gloria Reuben — award-winning actress, singer, author, and longtime HIV/AIDS advocate — will be honored at the 2025 Research in Action Awards (RIAA) for her unwavering dedication to public health, activism, and the arts.
Treatment Action Group (TAG) is proud to announce that Tom Postilio and Mickey Conlon — renowned philanthropists, internationally acclaimed real estate leaders, and dedicated advocates for public health — will serve as Event Chairs for the 2025 Research in Action Awards (RIAA).
Become a Monthly Donor Become one of our community of dedicated supporters by becoming a monthly donor to TAG. Your recurring contribution provides steady support for critical programs, groundbreaking research, and advocacy efforts to combat HIV, hepatitis C, and tuberculosis…
Treatment Action Group (TAG) is issuing an urgent call to protect the integrity of biomedical research and public health.
Treatment Action Group (TAG) decries the vicious and inchoate attacks on HHS since the advent of the new administration, which have escalated significantly over the past week.
The nomination of Dr. Jay Bhattacharya for Director of the United States National Institutes of Health (NIH) continues the pattern of un- and under-qualified nominees put forward by the current administration.
Treatment Action Group (TAG) is disgusted and appalled by the new presidential administration’s flagrant attack on science.